Current radiotherapy techniques in NSCLC: challenges and potential solutionsNiccolò Giaj‐Levra, Filippo Alongi, Paolo Borghetti et al.|Expert Review of Anticancer Therapy|2020Cited by 50
Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin’s lymphoma involving the mediastinumAndrea Riccardo Filippi, Gabriele Simontacchi, Sofia Meregalli et al.|Radiation Oncology|2020Cited by 32
The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: highlights from the 7th Meeting of AIRO--Young Members Working Group (AIRO Giovani).Pierfrancesco Franco, Filippo Alongi, Gianluca Mortellaro et al.|PubMed|2015Cited by 17
The Role of Stereotactic Ablative Radiotherapy in Oncological and Non-Oncological Clinical Settings: Highlights from the 7<sup>th</sup> Meeting of AIRO – Young Members Working Group (AIRO Giovani)Pierfrancesco Franco, Filippo Alongi, Berardino De Bari et al.|Tumori Journal|2014Cited by 15
The NIPRO Study: An Observational, Retrospective, Multicenter Study on the Safety of the Radiotherapy and Immunotherapy Combination for Advanced-Stage NSCLCMarco Perna, Alessio Bruni, Vieri Scotti et al.|Clinical Lung Cancer|2021Cited by 11